Crossmark

A randomised trial of non-invasive cardiac output monitoring to guide haemodynamic optimisation in high risk patients undergoing urgent surgical repair of proximal femoral fractures (ClearNOF trial NCT02382185)

Crossref DOI link: https://doi.org/10.1186/s13741-019-0119-x

Published Online: 2019-08-08

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Davies, S. J.

Yates, D. R.

Wilson, R. J. T.

Murphy, Z.

Gibson, A.

Allgar, V.

Collyer, T.
Funding

Funding for this research was provided by:

Edwards Lifesciences
License Information

Text and Data Mining valid from 2019-08-08

Version of Record valid from 2019-08-08
More Information

Article History

Received: 8 January 2019

Accepted: 30 June 2019

First Online: 8 August 2019

Ethics approval and consent to participate

: This study was approved by the NRES committee Yorkshire and the Humber Leeds West (14/YH/1170). Written informed consent was obtained by those individuals that held capacity; otherwise, if a patient met the inclusion criteria but lacked the capacity to consent, we followed the process outlined in the Mental Capacity Act and approved by the NRES committee.

: Not applicable

: SD, DY and RJTW have all received honorarium from Edwards Lifesciences Ltd for lecturing and consultancy work.

Document is current

Any future updates will be listed below